The survival of curaxins in the cancer arena
dc.contributor.author | Theocharous, G. | en |
dc.contributor.author | Papaspyropoulos, A. | en |
dc.contributor.author | Gorgoulis, Vassilis G | en |
dc.date.accessioned | 2023-08-09T10:07:31Z | |
dc.date.available | 2023-08-09T10:07:31Z | |
dc.date.issued | 2023 | en |
dc.identifier.citation | Theocharous G, Papaspyropoulos A, Gorgoulis V. The survival of curaxins in the cancer arena. BioEssays : news and reviews in molecular, cellular and developmental biology. 2023 Jul 11:e2300112. PubMed PMID: 37431695. Epub 2023/07/11. eng. | en |
dc.identifier.pmid | 37431695 | en |
dc.identifier.doi | 10.1002/bies.202300112 | en |
dc.identifier.uri | http://hdl.handle.net/10541/626451 | |
dc.description.abstract | With DNA damage being a primary anti-cancertarget, a need has arisen for the development of an approach that is a harmlessfor normal tissues but allows for cancer cell-specific cytotoxicity. Previous researchfrom K. Gurova's suggests that small compounds, namely curaxins that bind theDNA can cause chromatin instability and cell death in a cancer cell-specificmanner. In this brief perspective commentary, we investigate how the scientificcommunity has further developed this anti-cancer approach. | en |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1002/bies.202300112 | en |
dc.title | The survival of curaxins in the cancer arena | en |
dc.type | Article | en |
dc.contributor.department | Department of Histology and Embryology, Molecular Carcinogenesis Group, Medical School, National Kapodistrian University of Athens, Athens, Greece | en |
dc.identifier.journal | Bioessays | en |
dc.description.note | en] |